Weekly 24h infusion of aviscumine (rViscumin): A phase I study in patients with solid tumours

This publication has 16 references indexed in Scilit:

• Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: a study of the European Organization for Research and Treatment of Cancer New Drug Development Group
  Annals of Oncology, 2004
• Site-Specific Mutagenesis of Mistletoe Lectin: The Role of RIP Activity in Apoptosis
  Biochemical and Biophysical Research Communications, 1999
• Characterization of recombinant and plant‐derived mistletoe lectin and their B‐chains
  European Journal of Biochemistry, 1999
• How useful are unconventional cancer treatments?
  European Journal Of Cancer, 1999
• Cloning of the mistletoe lectin gene and characterization of the recombinant A‐chain
  European Journal of Biochemistry, 1999
• Effect of a Recombinant Lectin, Viscum album Agglutinin on the Secretion of Interleukin-12 in Cultured Human Peripheral Blood Mononuclear Cells and on NK-Cell-Mediated Cytotoxicity of Rat Splenocytes in vitro and in vivo
  Natural Immunity, 1998
• Complementary Medicine in Cancer Patients: Demand, Patient’ Attitudes and Psychological Beliefs
  Oncology Research and Treatment, 1998
• Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins
  Cancer Letters, 1996
• Mistletoe treatment for cancer review of controlled trials in humans
  Phytomedicine, 1994
• The site of action of the A‐chain of mistletoe lectin I on eukaryotic ribosomes The RNA N‐glycosidase activity of the protein
  FEBS Letters, 1988